Pitfalls in grading severity of chemotherapy-induced peripheral neuropathy
Open Access
- 1 July 1998
- journal article
- Published by Elsevier in Annals of Oncology
- Vol. 9 (7) , 739-744
- https://doi.org/10.1023/a:1008344507482
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- The European Organization for Research and treatment of cancer approach to quality of life assessment: guidelines for developing questionnaire modulesQuality of Life Research, 1993
- Assessing the Reliability of Two Toxicity Scales: Implications for Interpreting Toxicity DataJNCI Journal of the National Cancer Institute, 1993
- The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in OncologyJNCI Journal of the National Cancer Institute, 1993
- Evolution of neuropathy and myopathy during intensive vincristine/corticosteroid chemotherapy for non-hodgkin's lymphomaCancer, 1991
- Nerve growth factor prevents toxic neuropathy in miceAnnals of Neurology, 1991
- Comprehensive Criteria for Assessing Therapy-Induced ToxicityCancer Investigation, 1989
- Statistical evaluation of agreement between two methods for measuring a quantitative variableComputers in Biology and Medicine, 1989
- Reporting results of cancer treatmentCancer, 1981
- The Equivalence of Weighted Kappa and the Intraclass Correlation Coefficient as Measures of ReliabilityEducational and Psychological Measurement, 1973
- VINCRISTINE NEUROPATHYBrain, 1973